ELIZABETH COYLE to Humans
This is a "connection" page, showing publications ELIZABETH COYLE has written about Humans.
Connection Strength
0.120
-
A Critical Care Hybrid Online Elective Course for Third-Year Pharmacy Students. Am J Pharm Educ. 2016 Nov 25; 80(9):154.
Score: 0.014
-
Probable Nonconvulsive Status Epilepticus With the Use of High-Dose Continuous Infusion Ceftazidime. J Pharm Pract. 2016 Dec; 29(6):564-568.
Score: 0.013
-
Factors that influence student completion of course and faculty evaluations. Am J Pharm Educ. 2013 Mar 12; 77(2):27.
Score: 0.011
-
Clinical experience of linezolid in bone marrow transplantation patients. J Pharm Pract. 2010 Aug; 23(4):352-7.
Score: 0.009
-
Invasive candidiasis and the utility of antifungal susceptibility testing in the ICU. J Pharm Pract. 2010 Feb; 23(1):33-7.
Score: 0.009
-
Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2006 Aug; 50(8):2626-31.
Score: 0.007
-
Comparison of beta-lactams in counter-selecting resistance of Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2005 Jun; 52(2):145-51.
Score: 0.006
-
Association of Emotional Intelligence With Pharmacy Students' Leadership and Academic Performance. Am J Pharm Educ. 2024 Dec; 88(12):101335.
Score: 0.006
-
Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release. Antimicrob Agents Chemother. 2003 May; 47(5):1752-5.
Score: 0.005
-
Targeting bacterial virulence: the role of protein synthesis inhibitors in severe infections. Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2003 May; 23(5):638-42.
Score: 0.005
-
Activity of oritavancin (LY333328), an investigational glycopeptide, compared to that of vancomycin against multidrug-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model. Antimicrob Agents Chemother. 2001 Mar; 45(3):706-9.
Score: 0.005
-
Using the Theory of Planned Behavior to Evaluate Factors That Influence PharmD Students' Intention to Attend Lectures. Am J Pharm Educ. 2020 05; 84(5):7550.
Score: 0.004
-
A Study of the Relationship Between the PCOA and NAPLEX Using a Multi-institutional Sample. Am J Pharm Educ. 2019 03; 83(2):6867.
Score: 0.004
-
Point/Counterpoint: Are Outstanding Leaders Born or Made? Am J Pharm Educ. 2017 Apr; 81(3):58.
Score: 0.004
-
In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients. J Antibiot (Tokyo). 2014 Jul; 67(7):505-9.
Score: 0.003
-
Spectrum of gram-positive bacteraemia and in vitro activities of daptomycin, linezolid and vancomycin against organisms isolated from cancer patients. Int J Antimicrob Agents. 2013 Jun; 41(6):516-20.
Score: 0.003
-
Antifungal susceptibility testing: a primer for clinicians. Pharmacotherapy. 2012 Dec; 32(12):1112-22.
Score: 0.003
-
Escherichia coli resistance to quinolones at a comprehensive cancer center. Diagn Microbiol Infect Dis. 2010 Jul; 67(3):266-9.
Score: 0.002
-
Symposium on roles of and cooperation between academic- and practice-based pharmacy clinicians. Am J Health Syst Pharm. 2010 Feb 01; 67(3):231-8.
Score: 0.002
-
Significant publications on infectious diseases pharmacotherapy in 2007. Am J Health Syst Pharm. 2008 Nov 15; 65(22):e72-9.
Score: 0.002
-
Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia. J Antimicrob Chemother. 2005 May; 55(5):792-5.
Score: 0.002
-
Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. Clin Infect Dis. 2003 Dec 15; 37(12):1643-8.
Score: 0.001
-
Comparison of a rabbit model of bacterial endocarditis and an in vitro infection model with simulated endocardial vegetations. Antimicrob Agents Chemother. 2000 Jul; 44(7):1921-4.
Score: 0.001